Engineered bacteria secreting cytokines for use in cancer immunotherapy

Morten Otto Alexander Sommer (Inventor), Sarunas Tumas (Inventor), Ruben Vazquez-Uribe (Inventor), Scott Quainoo (Inventor)

Research output: Patent

39 Downloads (Pure)


The invention provides engineered bacteria that secretes cytokines, such as interleukin 2 (IL-2) cytokine, for use in cancer immunotherapy, pharmaceutical compositions comprising the engineered bacteria, methods for producing recombinant therapeutical polypeptides, and methods for using the engineered bacteria for therapeutic purposes.

Original languageEnglish
IPCC12N 15/ 62 A I
Patent numberWO2023161371
Filing date25/02/2022
Country/TerritoryInternational Bureau of the World Intellectual Property Organization (WIPO)
Priority date25/02/2022
Priority numberEP20220158950
Publication statusPublished - 31 Aug 2023


Dive into the research topics of 'Engineered bacteria secreting cytokines for use in cancer immunotherapy'. Together they form a unique fingerprint.

Cite this